Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

Moderna inks billion-dollar deal to settle long-running Spikevax dispute
Americas
Moderna settles, agreeing to part with up to $2.25 billion to avoid a trial and secure a licence to continue using the platform underpinning its COVID-19 vaccine.   5 March 2026
FisherBroyles opens San Diego office
Careers
Launch forms part of the firm’s continued national growth strategy, boosting its presence in “a vibrant ecosystem of technology, life sciences, wireless communications and emerging growth companies”.   4 March 2026
Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger
Careers
Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences and transatlantic services.   30 January 2026
Americas
The rise of fake online stores selling counterfeit pharmaceuticals is driving a surge in domain name disputes, forcing major brands to defend revenue and reputation.   28 January 2026
Careers
Global law firm and Wall Street institution to join forces, forming one of the world’s five largest law firms by revenue and significantly expanding global and US market reach.   22 December 2025
Americas
Israeli drug maker bows to FTC pressure, removing scores of “improperly listed” patents in boon for generic manufacturers.   11 December 2025
Careers
New hires bring “exceptional technical expertise” and a strong track record across biotechnology and pharmaceutical patent matters.   9 December 2025
Americas
Solicitor General urges the US Supreme Court to hear an appeal in its dispute, arguing that a ruling threatens the future of skinny labelling and the availability of lower-cost generics.   9 December 2025
Careers
Firm adds ex-DLA Piper litigator, who brings “deep technical experience” and “a proven track record” in complex patent and trade secrets cases.   3 December 2025
Europe
Even when legal teams do include women, the judges say they don’t always see or hear them, emphasising that visibility is critical for aspiring advocates.   27 November 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.